Validation of artificial skin equivalents as in vitro testing systems

被引:1
|
作者
Schmitt, Robert [1 ,2 ]
Marx, Ulrich [2 ]
Walles, Heike [3 ]
Schober, Lena [3 ]
机构
[1] Rhein Westfal TH Aachen, Lab Machine Tools & Prod Engn WZL, Steinbachstr 19, D-52074 Aachen, Germany
[2] Fraunhofer Inst Prod Technol IPT, D-52074 Aachen, Germany
[3] Fraunhofer Inst Interfacial Engn & Biotechnol IGB, D-70569 Stuttgart, Germany
关键词
Optical Coherence Tomography; OCT; Artificial Skin Equivalent; ASE; In Vitro Monitoring; Tissue Engineering; Tissue Optics; Image Processing; OPTICAL COHERENCE TOMOGRAPHY;
D O I
10.1117/12.873804
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
With the increasing complexity of the chemical composition of pharmaceuticals, cosmetics and everyday substances, the awareness of potential health issues and long term damages for humanoid organs is shifting into focus. Artificial in vitro testing systems play an important role in providing reliable test conditions and replacing precarious animal testing. Especially artificial skin equivalents ASEs are used for a broad spectrum of studies like penetration, irritation and corrosion of substances. One major challenge in tissue engineering is the qualification of each individual ASE as in vitro testing system. Due to biological fluctuations, the stratum corneum hornified layer of some ASEs may not fully develop or other defects might occur. For monitoring these effects we developed an fully automated Optical Coherence Tomography device. Here, we present different methods to characterize and evaluate the quality of the ASEs based on image and data processing of OCT B-scans. By analysing the surface structure, defects, like cuts or tears, are detectable. A further indicator for the quality of the ASE is the morphology of the tissue. This allows to determine if the skin model has reached the final growth state. We found, that OCT is a well suited technology for automatically characterizing artificial skin equivalents and validating the application as testing system.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Validation of in vitro systems
    Hartung, T.
    TOXICOLOGY LETTERS, 2005, 158 : S14 - S14
  • [22] Validation of sulfamethoxazole skin testing.
    Weber, EA
    Uetrecht, J
    Knowles, S
    Shear, N
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 1749 - 1749
  • [23] Interrelation of permeation and penetration parameters obtained from in vitro experiments with human skin and skin equivalents
    Wagner, H
    Kostka, KH
    Lehr, CM
    Schaefer, UF
    JOURNAL OF CONTROLLED RELEASE, 2001, 75 (03) : 283 - 295
  • [24] Validation of in vitro tests for skin corrosivity
    Fentem, JH
    ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN, 1999, 16 (03): : 150 - 153
  • [25] The validation of in vitro methods for skin irritation
    Botham, PA
    TOXICOLOGY LETTERS, 2004, 149 (1-3) : 387 - 390
  • [26] Design of artificial human keloid skin equivalents with collagen-based hydrogels
    Min, Lee Jong
    Hee, Kim Tae
    Dong-Hwee, Kim
    Youngmee, Jung
    TISSUE ENGINEERING PART A, 2022, 28 : 808 - 808
  • [27] Skin constructs for replacement of skin tissues for in vitro testing
    Ponec, M
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 : S19 - S30
  • [28] In vitro thrombogenicity testing of artificial organs
    Paul, R
    Marseille, O
    Hintze, E
    Huber, L
    Schima, H
    Reul, H
    Rau, G
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1998, 21 (09): : 548 - 552
  • [29] Preclinical Testing of Dendritic Core-Multishell Nanoparticles in Inflammatory Skin Equivalents
    Graff, Patrick
    Honzke, Stefan
    Joshi, Aaroh Anand
    Yealland, Guy
    Fleige, Emanuel
    Unbehauen, Michael
    Schafer-Korting, Monika
    Hocke, Andreas
    Haag, Rainer
    Hedtrich, Sarah
    MOLECULAR PHARMACEUTICS, 2022, 19 (06) : 1795 - 1802
  • [30] VALIDATION OF IN VITRO BIOASSAYS FOR 2,3,7,8-TCDD EQUIVALENTS
    SAFE, S
    MASON, G
    FARRELL, K
    KEYS, B
    PISKORSKAPLISZCZYNSKA, J
    MADGE, JA
    CHITTIM, B
    CHEMOSPHERE, 1987, 16 (8-9) : 1723 - 1728